Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Rothman

Showing results (201-210 of 262) with videos related to

Pageof 27
Sort By:
Pharmacology, Biochemistry, and Behavior|April 1, 1996
Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909G I Elmer, A Brockington, D A Gorelick, et al.
Life Sciences|January 1, 1993
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonistsR B Rothman, K M Becketts, L R Radesca, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatralineX H Gu, H Yu, A E Jacobson, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Journal of Medicinal Chemistry|September 16, 1994
A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of sigma receptor ligandsC M Bertha, M V Mattson, J L Flippen-Anderson, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moietyS Ananthan, C A Johnson, R L Carter, et al.
Journal of Medicinal Chemistry|April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacyS McLamore, T Ullrich, R B Rothman, et al.
Journal of Medicinal Chemistry|May 10, 1996
Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivityC M Bertha, M Ellis, J L Flippen-Anderson, et al.
Neuropeptides|May 1, 1984
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric modelR B Rothman, W D Bowen, V Bykov, et al.
Neuropharmacology|September 1, 1988
Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanismsJ A Danks, F C Tortella, J B Long, et al.
Pageof 27

Showing results (201-210 of 262) with videos related to

Sort By:
Pageof 27
Pharmacology, Biochemistry, and Behavior|April 1, 1996
Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909G I Elmer, A Brockington, D A Gorelick, et al.
Life Sciences|January 1, 1993
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonistsR B Rothman, K M Becketts, L R Radesca, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatralineX H Gu, H Yu, A E Jacobson, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Journal of Medicinal Chemistry|September 16, 1994
A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of sigma receptor ligandsC M Bertha, M V Mattson, J L Flippen-Anderson, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moietyS Ananthan, C A Johnson, R L Carter, et al.
Journal of Medicinal Chemistry|April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacyS McLamore, T Ullrich, R B Rothman, et al.
Journal of Medicinal Chemistry|May 10, 1996
Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivityC M Bertha, M Ellis, J L Flippen-Anderson, et al.
Neuropeptides|May 1, 1984
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric modelR B Rothman, W D Bowen, V Bykov, et al.
Neuropharmacology|September 1, 1988
Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanismsJ A Danks, F C Tortella, J B Long, et al.
Pageof 27